MedPath

Comparison of various advantages of drinking sugar rich water versus drinking coconut water before operations in patients who are going to have operations of the abdomen.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/05/068216
Lead Sponsor
Internal Fluid Research Grant
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age group 18-65 years

2. Patients undergoing elective, minor (level 2), intermediate (level 3) or high risk (level 4) abdominal surgeries involving upper and lower gastrointestinal tracts, hepatic resection or biliary reconstruction.

3. Patients undergoing inguinal, umbilical or incisional hernia repair.

4. All ASA1 and ASA 2 patients undergoing the above-mentioned surgeries who do not meet the exclusion criteria.

Exclusion Criteria

1. Patients having conditions that impair gastric emptying time – GERD, obesity, pregnancy, gastric outlet obstruction, intestinal obstruction, patients on certain pharmacological agents (like Morphine, tricyclic antidepressants, Levo-dopa) or patients who are unable to tolerate oral diet.

2. Patients having conditions affecting blood sugar level/ insulin level/ patient prone for dyselectrolytaemia – Diabetes Mellitus, Chronic Kidney Disease, Pancreatic tumor, or tumor involving pancreatic resection, adrenal insufficiency, or patients receiving colonic preparation prior to surgery.

3. Conditions that can affect the inflammatory markers- patients with sepsis, emergency procedures, and those undergoing oncological surgeries.

4. Patients undergoing very low risk (level 1) or very high risk (level 5) elective abdominal surgeries.

5. ASA 3, ASA 4 and ASA 5 patients.

6. Conditions that can affect glucose homeostasis- chronic liver disease, hyperthyroidism, HIV-AIDS, patients on steroid therapy.

7. Pregnant and lactating mothers.

8. Patients with BMI less than 18 or more than 30.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath